Lv11
10 积分 2023-06-30 加入
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
1小时前
已完结
Selective amylin receptor agonism: promise beyond incretins
1小时前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1小时前
已完结
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
2小时前
已完结
Amylin takes another shot at the obesity prize
4小时前
已完结
Binding sites and design strategies for small molecule GLP-1R Agonists
6天前
已完结
Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA
1个月前
已完结
Modern approaches to therapeutic oligonucleotide manufacturing
10个月前
已完结
The prevalence of drug patent term extensions in the United States, 2000–2018
1年前
已完结
Ancillary Product Patents to Extend Biologic Patent Life
1年前
已完结
皖公网安备34019202002308
